血管内超声对钝性胸主动脉损伤TEVAR临床结局的影响
基于VQI注册的919例钝性胸主动脉损伤行TEVAR患者的回顾性队列研究显示,使用血管内超声(IVUS)者损伤严重度评分更高、更多为III级损伤、破裂更少,但IVUS使用与院内及1年生存率或再干预率无差异。
核心结论
- IVUS用于钝性胸主动脉损伤TEVAR时,患者更稳定且干预可延迟,但总体临床结局与未使用IVUS者相似。
研究设计与样本
- 回顾性队列研究,基于VQI注册数据库,纳入919例因钝性胸主动脉损伤行TEVAR的患者,按是否使用IVUS分组。
临床怎么用
- IVUS可用于血流动力学更稳定、可延迟干预的钝性胸主动脉损伤患者,以辅助主动脉尺寸测量,但需认识到其并未显示改善临床结局。
局限性
- 回顾性研究设计,无法评估血流动力学状态及主动脉或内支架尺寸差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Thoracic endovascular aortic repair (TEVAR) for blunt traumatic aortic injuries (BTAIs) can be complicated by inaccurate aortic measurements at the initial computed tomography angiography secondary to hypovolemic shock. The use of intravascular ultrasound (IVUS) has been proposed for more accurate aortic sizing, with prior data demonstrating larger aortic sizes measured by IVUS, potentially altering the vast majority of chosen endograft sizes. At present, and to the best of our knowledge, no studies have examined whether IVUS affects the clinical outcomes. The purpose of the present study was to examine the effect of IVUS on the clinical outcomes after TEVAR for BTAIs. METHODS: A retrospective cohort study was performed of patients who had undergone TEVAR for BTAIs in the VQI registry. The cohorts were defined by the use of IVUS. The primary outcomes were mortality and reintervention at 1 year. RESULTS: A total of 919 patients who had undergone TEVAR for BTAIs were included in the present analysis. The IVUS patients had presented with higher injury severity scores (36.2 vs 42; P = .0004) largely because of more extremity and external trauma. IVUS was more often used for patients with grade III injuries (49.1% vs 56.9%; P = .02) and less often for patients with rupture (21.1% vs 12.4%; P = .001). A trend toward a delay in TEVAR was seen for the patients for whom IVUS was used (1.8 vs 3.5 days; P = .38), with additional trends toward reduced intraoperative resuscitation and blood loss. The hemodynamic status of the patients and differences in aortic or endograft sizes could not be assessed with the available data. IVUS use was not associated with any differences in survival or reintervention rates in-hospital or at 1 year (Kaplan-Meier survival estimates: 0.91 no IVUS vs 0.92 IVUS; P = .46). Fifteen aortic-related reinterventions occurred across the entire patient cohort for all-available follow-up with comparable rates of type I endoleaks (1 no IVUS vs 2 IVUS), with no recorded cases of sizing-related complications such as device rupture, migration, or dissection. CONCLUSIONS: IVUS usage during TEVAR for BTAIs was associated with clinical scenarios in which patients were more stable and interventions to address BTAIs can be delayed. Despite this, the overall clinical outcomes were similar between cases in which IVUS was used and for which it was not.
引用
- Smith JA, Bose S, Sarode A, et al. Effect of intravascular ultrasound on clinical outcomes after thoracic endovascular aortic repair for blunt thoracic aortic injury. J Vasc Surg. 2021. PMID: 34506893. doi:10.1016/j.jvs.2021.08.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。